My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about GKOS

Recent news which mentions GKOS

< Previous 1 2 3 4 Next >
Stifel Maintains Buy Rating for Glaukos: Here's What You Need To Know
Tickers GKOS
Tags Analyst Ratings Benzinga Market News
From Benzinga
8 Analysts Have This to Say About Glaukos
Tickers GKOS
Tags GKOS Market News Analyst Ratings
From Benzinga
Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade
Tickers GKOS
Tags Benzinga Briefs Upgrades
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Tickers AMED AUR BOH CHEK
Tags Upgrades SMCI MBLY
From Benzinga
Analyst Expectations for Glaukos's Future
Tickers GKOS
Tags Analyst Ratings BZI/AAR Benzinga
From Benzinga
Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday
Tickers DISH GKOS MCK PYPL
Tags Health Care Distributors Stocks To Watch Markets
From Benzinga
Glaukos: Q1 Earnings Insights
Tickers GKOS
Tags GKOS Earnings Benzinga
From Benzinga
Expert Ratings for Glaukos
Tickers GKOS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It
Tickers GKOS SGHT SKYE
Tags Small Cap Market News SKYE
From Benzinga
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
Tickers CAKE CI ETSY GKOS
Tags Trading Ideas TGT WIX
From Benzinga
Earnings Preview For Glaukos
Tickers GKOS
Tags Market News Benzinga Earnings
From Benzinga
Analyst Expectations for Glaukos's Future
Tickers GKOS
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
10 Analysts Have This to Say About Glaukos
Tickers GKOS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
What 10 Analyst Ratings Have To Say About Glaukos
Tickers GKOS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Tickers AGEN ALC APLD BAM
Tags FATE Upgrades NKTX
From Benzinga
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
Tickers GKOS SGHT SKYE
Tags Benzinga SGHT General
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Tickers ACST ACXP AEL AEP
Tags NAMS PKI TMPO
From Benzinga
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Tickers ATRC ATXS COP GKOS
Tags Market News PGNY LHX
From Benzinga
7 Analysts Have This to Say About Glaukos
Tickers GKOS
Tags GKOS BZI/AAR Benzinga
From Benzinga
Analyst Ratings for Glaukos
Tickers GKOS
Tags GKOS Benzinga BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Tickers ACHC ACN ACRV ADI
Tags WOLF HEI CW
From Benzinga
Where Glaukos Stands With Analysts
Tickers GKOS
Tags Analyst Ratings BZI/AAR Benzinga
From Benzinga
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
Tickers ATUS CTSH ERII FIS
Tags ERII PLMR PANW
From Benzinga
What 4 Analyst Ratings Have To Say About Glaukos
Tickers GKOS
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock
Tickers GKOS
Tags GKOS Briefs Price Target
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV APLS AXSM BIIB
Tags UNH Market News AXSM
From Benzinga
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
Tickers ADTH AKA AMRS AQST
Tags NUTX BIAF LTCH
From Benzinga
Why Glaukos Stock Zoomed Nearly 19% Higher Today
Tickers GKOS
Tags Recent Press Releases Market News GKOS
From Motley Fool
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
Tickers BCYC DBVT ERAS GKOS
Tags Health Care DBVT VIRX
From Benzinga
Dow Jumps 450 Points; UiPath Shares Slide
Tickers AZRE CLAQ GKOS GPL
Tags IMRA Markets GPL
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.